Inotuzumab Ozogamicin and Combination Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia
Conditions
- B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1
- B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative
- Burkitt-Like Lymphoma With 11q Aberration
- High Grade B-Cell Lymphoma With MYC and BCL2 and/or BCL6 Rearrangements
- High Grade B-Cell Lymphoma, Not Otherwise Specified
- Recurrent B Acute Lymphoblastic Leukemia
- Recurrent Burkitt Lymphoma
- Refractory B Acute Lymphoblastic Leukemia
- Refractory Burkitt Lymphoma
Interventions
- BIOLOGICAL: Blinatumomab
- DRUG: Cyclophosphamide
- DRUG: Cytarabine
- DRUG: Dexamethasone
- BIOLOGICAL: Inotuzumab Ozogamicin
- OTHER: Laboratory Biomarker Analysis
- DRUG: Mercaptopurine
- DRUG: Methotrexate
- DRUG: Prednisone
- BIOLOGICAL: Rituximab
- DRUG: Vincristine
Sponsor
M.D. Anderson Cancer Center
Collaborators